Trouble Falling Asleep: Labs, Diagnosis, and Next Steps

What Counts as "Trouble Falling Asleep"

Sleep-onset insomnia means consistently taking 30 minutes or longer to transition from full wakefulness to sleep, occurring on three or more nights per week and persisting for at least three months. The International Classification of Sleep Disorders, Third Edition (ICSD-3), codifies this as chronic insomnia disorder when it produces daytime impairment such as fatigue, mood disturbance, or reduced concentration [1].

Subjective vs. Objective Sleep Latency

Patients tend to overestimate how long they lie awake. A 2019 meta-analysis published in Sleep Medicine Reviews (N=781 across 23 studies) found that subjective sleep-onset latency exceeded objective actigraphy-measured latency by an average of 28 minutes [2]. This discrepancy does not invalidate the complaint. The American Academy of Sleep Medicine (AASM) recognizes that perceived sleep difficulty itself drives clinical distress and functional impairment [3].

When Occasional Becomes Chronic

One restless night before a job interview is normal. Three months of staring at the ceiling is not. The distinction matters because chronic insomnia rewires arousal circuitry. A 2018 study in The Lancet Psychiatry (N=2,224) demonstrated that prolonged insomnia subtypes carry different neurobiological signatures, with the "highly distressed" subtype showing elevated hypothalamic-pituitary-adrenal (HPA) axis activity even during daytime hours [4].

Why You Might Have Trouble Falling Asleep

Sleep-onset difficulty is rarely a single-cause problem. A useful clinical framework separates predisposing, precipitating, and perpetuating factors. Spielman's 3-P model, introduced in 1987 and still cited in current AASM practice guidelines, explains why insomnia persists long after the original trigger resolves [5].

Medical Causes Worth Ruling Out

Thyroid dysfunction tops the list. Hyperthyroidism increases sympathetic tone, heart rate, and body temperature, all of which oppose sleep onset. A cross-sectional analysis of NHANES data (N=4,951) found that participants with subclinical hyperthyroidism (TSH <0.4 mIU/L) had 1.6 times the odds of reporting sleep-onset difficulty compared with euthyroid controls [6].

Iron deficiency is another underrecognized contributor. Ferritin below 50 ng/mL is associated with restless legs syndrome (RLS), which delays sleep onset. The AASM's 2012 RLS practice parameter recommends checking serum ferritin in any patient with difficulty initiating sleep who also reports leg discomfort or an urge to move [7].

Other conditions to evaluate: cortisol dysregulation (evening salivary cortisol above 0.2 µg/dL suggests HPA axis hyperactivation), prediabetes or diabetes (glycemic variability causes nocturnal arousal), chronic pain syndromes, and medication effects from SSRIs, stimulants, corticosteroids, or beta-agonist inhalers.

Behavioral and Psychological Drivers

Hyperarousal is measurable. A landmark study by Bonnet and Arand (1997) showed that insomnia patients have higher 24-hour metabolic rates, elevated heart rates, and increased high-frequency EEG activity compared with matched controls [8]. This is not "just stress." It is a physiological state.

Conditioned arousal, where the bed becomes a cue for wakefulness rather than sleep, is the perpetuating factor that CBT-I specifically targets. Screen exposure, irregular schedules, and caffeine after 2 PM are common precipitants, but they become less important than the conditioned association once chronic insomnia is established.

Which Labs to Request

Not every patient with insomnia needs lab work. But when sleep-onset difficulty is persistent, unexplained by behavioral factors alone, or accompanied by other symptoms (fatigue, weight changes, mood shifts, hair loss), targeted labs can identify treatable causes.

The Core Panel

A reasonable first-pass order includes:

• TSH and free T4 to screen for hyper- or hypothyroidism. The American Thyroid Association recommends TSH as the initial screen, with free T4 added if TSH is abnormal [9].
• Serum ferritin (not just a CBC). Ferritin can be low even with a normal hemoglobin. Target above 50 ng/mL for sleep-related complaints.
• Fasting glucose and/or HbA1c. The American Diabetes Association defines prediabetes as HbA1c 5.7-6.4% [10]. Glycemic instability can drive nocturnal cortisol spikes and awakenings.
• Evening salivary cortisol. A value above 0.2 µg/dL collected between 11 PM and midnight suggests Cushing syndrome or non-pathological HPA hyperactivation. The Endocrine Society's 2008 guidelines recommend this as a screening test when clinical suspicion exists [11].

When to Add Specialized Tests

Vitamin D (25-hydroxyvitamin D) has an emerging but not definitive link to sleep quality. A 2018 meta-analysis in Nutrients (N=9,397 across 9 studies) found that vitamin D deficiency (<20 ng/mL) was associated with a 1.5-fold increase in poor sleep quality, though causation remains unproven [12]. Ordering it is reasonable when levels may be low (northern latitudes, limited sun exposure, darker skin).

Magnesium (RBC magnesium, not serum) may be relevant in patients with muscle cramps, anxiety, or palpitations. Serum magnesium reflects only 1% of total body stores and is a poor screening test. A 2012 double-blind RCT in the Journal of Research in Medical Sciences (N=46, adults over 60) found that 500 mg of magnesium supplementation for 8 weeks significantly improved subjective sleep quality and increased serum melatonin [13].

Testosterone (total and free) should be considered in men over 40 with concurrent low energy, decreased libido, and increased visceral fat. The Endocrine Society's 2018 hypogonadism guideline recommends morning total testosterone as the initial test [14]. Low testosterone is independently associated with disrupted sleep architecture, though it more commonly causes sleep fragmentation than pure onset difficulty.

How Sleep-Onset Insomnia Is Diagnosed

The diagnosis is clinical. No blood test confirms insomnia. Labs exist to exclude mimics.

The Clinical Interview

A structured sleep history covers: bedtime, wake time, time to fall asleep, number of awakenings, nap habits, caffeine and alcohol intake, medication list (prescription and OTC), shift work, and screen use. The AASM's clinical guideline (2021 update) identifies the clinical interview as the single most important diagnostic tool [3].

Two validated questionnaires add objectivity:

• Insomnia Severity Index (ISI): A 7-item self-report measure. Scores above 14 indicate moderate clinical insomnia. The ISI has a sensitivity of 86% and specificity of 88% against clinical diagnosis [15].
• Pittsburgh Sleep Quality Index (PSQI): Global scores above 5 indicate poor sleep quality, with a diagnostic sensitivity of 89.6% and specificity of 86.5% for insomnia [16].

The Sleep Diary

Two weeks of daily logging. Patients record when they got into bed, when they tried to sleep, estimated time to fall asleep, wake-ups during the night, final wake time, and out-of-bed time. This data is more accurate than recall during a clinic visit and is required before starting CBT-I [3].

Actigraphy and Polysomnography

Wrist actigraphy (a motion-sensing device worn for 1-2 weeks) provides objective estimates of sleep-wake patterns. It is useful when there is a significant mismatch between subjective complaints and suspected sleep duration, or to document circadian rhythm disorders.

Polysomnography (an overnight in-lab sleep study) is not indicated for straightforward insomnia. The AASM's 2017 practice guideline reserves polysomnography for cases where obstructive sleep apnea, periodic limb movement disorder, or narcolepsy is clinically suspected [17]. Ordering a sleep study "just to check" for a patient whose primary complaint is difficulty falling asleep is not standard of care.

First-Line Treatment: CBT-I

Cognitive behavioral therapy for insomnia is the recommended first-line treatment by the AASM, the American College of Physicians (ACP), and the European Sleep Research Society. The ACP's 2016 clinical practice guideline states: "We recommend that all adult patients receive CBT-I as the initial treatment for chronic insomnia disorder" [18].

What CBT-I Actually Involves

The protocol runs 4 to 8 sessions (weekly, with a trained provider or via a validated digital platform) and includes five components:

1. Sleep restriction therapy. Limiting time in bed to match actual sleep duration. A patient sleeping 5.5 hours but spending 8 hours in bed would be prescribed a 6-hour sleep window, titrated upward weekly as efficiency improves.
2. Stimulus control. Bed is for sleep and sex only. If unable to sleep within approximately 20 minutes, the patient gets up and returns only when drowsy.
3. Cognitive restructuring. Identifying and correcting catastrophic beliefs about sleep ("If I don't sleep 8 hours, I won't function tomorrow").
4. Sleep hygiene education. Consistent wake time, cool bedroom (65-68°F), no caffeine after early afternoon, dim lights 1 hour before bed.
5. Relaxation training. Progressive muscle relaxation or diaphragmatic breathing.

Efficacy Data

A 2015 meta-analysis in Annals of Internal Medicine (20 RCTs, N=1,162) found that CBT-I reduced sleep-onset latency by an average of 19.03 minutes (95% CI: 14.12-23.93) and improved sleep efficiency by 9.91 percentage points [19]. Effects persisted at 12-month follow-up, unlike pharmacotherapy, where rebound insomnia is common after discontinuation.

Digital CBT-I programs (such as the FDA-cleared Pear Therapeutics' Somryst, now Mahana) produce effect sizes comparable to in-person delivery. A 2016 RCT in JAMA Psychiatry (N=303) using the SHUTi platform showed a remission rate of 56.6% vs. 27.0% for the online education control [20].

Access Challenges

Fewer than 1% of U.S. Psychologists are trained to deliver CBT-I. Wait times for specialized providers average 4 to 8 weeks in metropolitan areas and longer in rural settings. The Veterans Affairs system has been a leader in training CBT-I providers, offering the protocol across all VA medical centers as of 2022. Digital platforms partially address this gap but require self-motivation and consistent engagement.

Pharmacotherapy: When and What

Medications are second-line. The ACP's guideline recommends discussing pharmacotherapy only when CBT-I alone is insufficient or unavailable [18].

Short-Term Options

Melatonin (0.5-1 mg, 30-60 minutes before target sleep time): Lower doses are more physiologic. A 2013 meta-analysis in PLOS ONE (19 RCTs, N=1,683) found melatonin reduced sleep-onset latency by 7.06 minutes (95% CI: 4.37-9.75) and increased total sleep time by 8.25 minutes [21]. Modest effect, but the safety profile is excellent and there is no withdrawal risk.

Suvorexant (Belsomra, 10 mg) and lemborexant (Dayvigo, 5 mg): Dual orexin receptor antagonists (DORAs) block the wakefulness-promoting orexin system. A pooled analysis of suvorexant phase III trials (N=3,291) showed a reduction in subjective sleep-onset latency of approximately 20 minutes vs. Placebo at 3 months [22]. DORAs have a lower abuse potential than benzodiazepine receptor agonists and do not suppress deep sleep.

What to Avoid Long-Term

Benzodiazepines (temazepam, triazolam) and Z-drugs (zolpidem, zaleplon) carry FDA boxed warnings for complex sleep behaviors, tolerance, and dependence. The AASM's 2017 systematic review of pharmacotherapy found that long-term data (>12 weeks) for these agents are insufficient, and harms increase in older adults, including a dose-dependent increase in fall risk [23].

Diphenhydramine (Benadryl) and doxylamine (Unisom SleepTabs) are not recommended for insomnia at any duration. Their anticholinergic burden contributes to cognitive impairment, urinary retention, and next-day sedation. The American Geriatrics Society Beers Criteria lists them as potentially inappropriate for adults 65 and older [24].

Hormonal Contributors to Sleep-Onset Difficulty

Cortisol and the HPA Axis

The normal cortisol rhythm peaks 30 to 45 minutes after waking (the cortisol awakening response) and reaches its nadir around midnight. Chronic stress, shift work, or HPA dysregulation can flatten or invert this curve, producing elevated evening cortisol that directly antagonizes melatonin-driven sleep onset.

A 2017 study in Psychoneuroendocrinology (N=104) found that evening salivary cortisol was significantly higher in participants with insomnia compared to good sleepers (mean 0.15 vs. 0.08 µg/dL, P=0.003) [25]. Addressing the root cause, whether it is a behavioral pattern, medication effect, or endocrine disorder, is more effective than suppressing cortisol pharmacologically.

Thyroid Hormones

Both hyperthyroidism and hypothyroidism disrupt sleep, but through different mechanisms. Hyperthyroidism causes hyperarousal, tachycardia, and thermogenic discomfort. Hypothyroidism is more commonly associated with excessive daytime sleepiness and sleep-disordered breathing rather than difficulty falling asleep. If TSH is suppressed and free T4 is elevated, endocrinology referral and beta-blocker therapy (propranolol 10-20 mg) can provide symptomatic relief while definitive treatment is initiated [9].

Estrogen, Progesterone, and Perimenopause

Up to 56% of perimenopausal women report insomnia symptoms, compared to 31% of premenopausal women, according to the Study of Women's Health Across the Nation (SWAN, N=3,045) [26]. Progesterone metabolites (specifically allopregnanolone) are positive allosteric modulators of GABA-A receptors. Declining progesterone during perimenopause reduces GABAergic tone, directly impairing sleep initiation.

The North American Menopause Society (NAMS) 2022 position statement notes that hormone therapy may improve sleep quality in menopausal women with concurrent vasomotor symptoms, though it is not approved as a primary insomnia treatment [27].

When to See a Specialist

Most sleep-onset insomnia can be managed in primary care. Referral to a sleep medicine specialist is appropriate when:

• The patient does not respond to 8 sessions of CBT-I plus behavioral changes.
• Polysomnography-requiring diagnoses (obstructive sleep apnea, narcolepsy, advanced or delayed sleep-wake phase disorder) are suspected.
• The patient is using hypnotic medications nightly for longer than 4 weeks and cannot taper.
• Psychiatric comorbidity (PTSD, bipolar disorder, severe anxiety disorder) is driving the insomnia and requires integrated treatment.

A sleep medicine board-certified physician can conduct a formal evaluation, order and interpret polysomnography or home sleep apnea testing, and prescribe specialized chronotherapy protocols. The AASM maintains a provider directory at sleepeducation.org for patient referrals.

Practical Next Steps for Tonight

Start before the lab results come back. Keep a consistent wake time, even on weekends. Remove the clock from your line of sight (clock-watching increases arousal). Set a "screens-off" alarm 60 minutes before your target bedtime. Keep the bedroom at 65-68°F. If you are not asleep within approximately 20 minutes, get up, go to a dimly lit room, and do something non-stimulating until drowsy. Return to bed only when sleepy. Repeat as needed. This stimulus-control protocol alone reduced sleep-onset latency by 24 minutes in a 2006 RCT (N=82) published in Sleep [28].